Active Ingredient History

  • Now
Pridopidine is an orally administrated small molecule investigational drug. Pridopidine is a selective and potent Sigma-1 Receptor agonist. It is being developed by Prilenia Therapeutics and is currently in late-stage clinical development for Huntington’s disease (HD) and Amyotrophic Lateral Sclerosis (ALS).   Wikipedia

  • SMILES: CCCN1CCC(CC1)c2cccc(c2)S(=O)(=O)C
  • Mol. Mass: 281.42
  • ALogP: 2.68
  • ChEMBL Molecule:
More Chemistry
4-(3-methanesulfonylphenyl)-1-propylpiperidine | 4-(3-(methylsulfonyl)phenyl)-1-propylpiperidine | acr16 | acr16 compound | fr-310826 | huntexil | pridopidine


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue